Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: A clinical study in normal volunteers

Yakugaku Zasshi

Volumn 121, Issue 5, 2001, Pages 355-364

  Kubota, Rie ^a   Komiyama, Takako ^a   Shimada, Hideyo ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Hypertension; Nifedipine; Pharmacokinetics; Sublingually

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; INTESTINE MUCOSA; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; NIFEDIPINE;

EID: 0035021753     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.121.355     Document Type: Article

References (29)

1. Hart L. L., Mowers R. M., Drug Intell. Clin. Pharm., 21, 432-433 (1987).
2. Grossman D., Messerli F. H., Grodzicki T., Kowey P., JAMA, 276, 1328-1331 (1996).
3. Kubota R., Kumazawa J., Komiyama T., JJSHP, 34, 1341-1346 (1998).
4. Miyazaki K., Kohri N., Arita T., J. Chromatogr., 310, 219-222 (1984).
5. Kohri N., Miyazaki K., Arita T., Shimono H., Nomura A., Yasuda H., Chem. Pharm. Ball., 35, 2504-2509 (1987).
6. Takebe M., Azuma J., Yafune A., Tei S., Kishimoto S., Jpn. J. Clin. Pharmacol. Ther., 20, 139-140 (1989).
7. Beer N., Gallegos I., Cohen A., Klein N., Sonnenblick E., Frishman W., Chest, 79, 571-574 (1981).
8. Ellrodt A. G., Ault M. J., Riedinger M. S., Murata G. H., Am. J. Med., 79, 19-25 (1985).
9. Abraham G., Shukkur A., van der Meulen J., Johny K. V., Br. J. Clin. Pract., 40, 478-481 (1986).
10. Haft J. I., Litterer III W. E., Arch. Intern. Med., 144, 2357-2359 (1984).
11. Krichbaum D. W., Malone P. M., Drug Intell. Clin. Pharm., 22, 891-892 (1988).
12. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Arch. Intern. Med., 157, 2413 -2446 (1997).
13. Ferguson R. K., Vlasses P. H., JAMA, 255, 1607-1613 (1986).
14. Brown G. R., Fraser D. G., Castile J. A., Gaudreault P., Platt D. R., Friedman P. A., Int. J. Clin. Pharmacol. Ther. Toxicol., 24, 283-286 (1986).
15. Mcallister R. G., Am. J. Med., 81, 2-5 (1986).
16. Van Harten J., Burggraaf K., Danhof M., van Brummelen P., Lancet, 2, 1363-1365 (1987).
17. Lopez-Herce J., Dorao P., Ruza F., de la Oliva P., Crit. Care. Med., 16, 914 (1988).
18. Aoki K., Sato K., Kawaguchi Y., Yamamoto M., Eur. J. Clin. Pharmacol., 23, 197-201 (1982).
19. Hanawa K., Kobayashi H., Togashi M., Tsuzuki M., Fujise Y., Iimura O., Rinsho to Kenkyu, 59, 1703-1712 (1982).
20. Kikuchi K., Kobayashi H., Nakao T., Kondo A., Mito T., Tsuzuki M., Iimura O., Fujise Y., Hanawa K., Jpn. J. Clin. Pharmacol. Ther., 13, 623-637 (1982).
21. Kleinbloesem C. H., van Brummelen P., van de Linde J. A., Voogd P. J., Breimer D. D., Clin. Pharmacol. Ther., 35, 742-749 (1984).
22. Traube M., Hongo M., McAllister Jr R. G., McCallum R. W., J. Clin. Pharmacol., 25, 125-129 (1985).
23. Kleinbloesem C. H., van Brummelen P., Breimer D. D., Clin. Pharmacokinet., 12, 12-29 (1987).
24. Walley T. J., Heagerty A. M., Woods K. L., Pohl J. E., Barnett D. B., Br. J. Clin. Pharmac., 23, 693-701 (1987).
25. Graefe K. H., Ziegler R., Wingender W., Ramsch K. D., Schmitz H., Clin. Pharmacol. Ther., 43, 16-22 (1988).
26. Holford N. H., Sheiner L. B., Clin. Pharmacokinet., 6, 429-453 (1981).
27. Kleinbloesem C. H., van Brummelen P., Danhof M., Clin. Pharmacol. Ther., 41, 26-30 (1987).
28. Kleinbloesem C. H., van Harten J., de Leede L. G. J., van Brummelen P., Breimer D. D., Clin. Pharmacol. Ther., 36, 396-401 (1984).
29. Waller D. G., Renwick A. G., Gruchy B. S., George C. F., Br. J. Clin. Pharmac., 18, 951-954 (1984).